Binosto Manuals & User Guides

FULL PRESCRIBING INFORMATION INDICATIONS AND USAGE 1.1 Treatment of Osteoporosis in Postmenopausal Women BINOSTO effervescent tablet 70 mg is indicated for the treatment of osteoporosis in postmenopausal women. For the…

This label may not be the latest approved by FDA. For current labeling information, please visit https://www.fda.gov/drugsatfda Medication Guide BI N OSTO™ (BIN-oss-tow) ( alendronate sodium ) Effervescent Tablets Read…

Discover BINOSTO® (alendronate sodium) effervescent tablets, a bisphosphonate medication for treating osteoporosis in postmenopausal women and increasing bone mass in men. This guide details indications, dosage, warnings, and more.